| Altrecia L Jackson, LPN | |
|
7209 Louise St, Shreveport, LA 71108-4844 | |
| (318) 344-8365 | |
| Not Available |
| Full Name | Altrecia L Jackson |
|---|---|
| Gender | Female |
| Speciality | Case Manager/care Coordinator |
| Location | 7209 Louise St, Shreveport, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114459666 | NPI | - | NPPES |
| 880566 | Other | LA | LPN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 880566 (Louisiana) | Secondary |
| 171M00000X | Case Manager/care Coordinator | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Altrecia L Jackson, LPN 3341 Youree Drive, Shreveport, LA 71105 Ph: (318) 344-8365 | Altrecia L Jackson, LPN 7209 Louise St, Shreveport, LA 71108-4844 Ph: (318) 344-8365 |
News Archive
Two kids climb into an empty shopping cart and launch themselves down a hill. If you're an adult, you can imagine what happens next; if you're 6 and trying to impress your little brother, not so much.
After four years of conducting intensive calculations in the supercomputer MareNostrum at the Barcelona Supercomputing Center, scientists headed by Modesto Orozco at the Institute for Research in Biomedicine (IRB Barcelona) have presented the world's largest data base on protein motions. Called MoDEL, this new database holds more than 1,700 proteins and is partially accessible through Internet to researchers worldwide. MoDEL has been developed to study the basic biology of proteins and to accelerate and facilitate the design of new pharmaceutical agents.
A new approach to evaluating a person's risk of cardiovascular disease, stroke, high blood pressure, or heart failure is reported this month in the International Journal of Data Mining, Modelling and Management. The technique uses fuzzy logic to teach a neural network computer program to analyze patient data and spot correlations that can be translated into a risk factor for an individual.
Cortex Pharmaceuticals, Inc. announced that it has entered into an agreement with Biovail Laboratories International SRL in which Biovail acquired certain AMPAKINE compounds and the rights to the patent filing for respiratory depression and vaso-occlusive crises associated with sickle cell disease.
› Verified 9 days ago